These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25831719)

  • 1. [Current status and issues in early & exploratory oncology clinical trials in Japan].
    Ohtsu A
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():23-9. PubMed ID: 25831719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status and issues in clinical trials of anticancer agents].
    Kojima H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
    Forster MD; Saijo N; Seymour L; Calvert H
    Clin Cancer Res; 2010 Mar; 16(6):1737-44. PubMed ID: 20215555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of Japan to develop new anticancer agents].
    Sajjo N
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):242-6. PubMed ID: 8611054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 0 clinical trials in oncology: an exploratory methodology for constructing a study with patients undergoing surgery for metastatic disease.
    Pocard M; Soria JC; Aldaz-Carroll L; Bellet D
    J Clin Oncol; 2010 Oct; 28(30):4551-3. PubMed ID: 20837954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current Status and Future Perspectives of SCRUM-Japan].
    Ohtsu A; Goto K; Yoshino T; Okamoto W; Tsuchihara K
    Gan To Kagaku Ryoho; 2017 Aug; 44(8):621-626. PubMed ID: 28860428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRC as a potential therapeutic target in solid tumor oncology.
    Gallick GE
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):435-7. PubMed ID: 16163218
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of oral anticancer drugs in Japan.
    Fujiwara Y
    J Clin Oncol; 1999 Oct; 17(10):3362-5. PubMed ID: 10506642
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidermal growth factor receptor inhibitors: current status and future directions.
    Chen HX; Cleck JN; Coelho R; Dancey JE
    Curr Probl Cancer; 2009; 33(4):245-94. PubMed ID: 20082842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto CH
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
    Andoh M; Fujiwara Y; Shimada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 15. BMS and Exelixis target tumor suppression pathways.
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):167. PubMed ID: 12113021
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinued drugs in 2008: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aiming for the future: clinical trials study the personalized treatments of tomorrow.
    Coghill AS
    ONS Connect; 2013 Dec; 28(4):36-40. PubMed ID: 24400579
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncology trials gear up for high-throughput sequencing.
    Mullard A
    Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer drugs: restrictions recommended.
    Swinbanks D
    Nature; 1989 Dec 21-28; 342(6252):843. PubMed ID: 2687697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Emetogenic potential of antineoplastic agents based on clinical trials in Japan].
    Watanabe T; Handa S; Kato Y
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):335-41. PubMed ID: 25812503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.